Literature DB >> 9004502

The antibacterial action of protamine: evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium.

A Aspedon1, E A Groisman.   

Abstract

Protamine is a polycationic peptide found in the nuclei of sperm of different animal species. While it has long been known to have antimicrobial properties, its mode of action has remained elusive. We have investigated the mechanism of action of protamine and established that this peptide exerts its antibacterial effect without causing cell lysis or permeabilization of the cytoplasmic membrane. Respiring cells were more susceptible than nonrespiring cells, and loss of viability could be prevented by incubation at low pH or the addition of respiratory poisons. This indicates that protamine activity is influenced by the electrical membrane potential (delta psi): increased killing occurs at higher delta psi values. Protamine caused inhibition of proline uptake, rapid efflux of proline from preloaded cells, and a reduction in the cellular ATP content. Furthermore, protamine-treated cells first lost the ability to accumulate leucine and then could not carry out protein synthesis. Cumulatively, our data indicate that protamine disrupts energy transduction and nutrient uptake functions, and suggest that the cytoplasmic membrane is the target of protamine action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004502     DOI: 10.1099/13500872-142-12-3389

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  23 in total

Review 1.  Osmosensing by bacteria: signals and membrane-based sensors.

Authors:  J M Wood
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

2.  The CpxR/CpxA two-component system up-regulates two Tat-dependent peptidoglycan amidases to confer bacterial resistance to antimicrobial peptide.

Authors:  Natasha Weatherspoon-Griffin; Guang Zhao; Wei Kong; Ying Kong; Helene Andrews-Polymenis; Michael McClelland; Yixin Shi
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

3.  Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides.

Authors:  S P Koo; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases.

Authors:  Wiebke Arendt; Stefanie Hebecker; Sonja Jäger; Manfred Nimtz; Jürgen Moser
Journal:  J Bacteriol       Date:  2012-01-20       Impact factor: 3.490

5.  Effects of histatin 5 and derived peptides on Candida albicans.

Authors:  A L Ruissen; J Groenink; E J Helmerhorst; E Walgreen-Weterings; W Van't Hof; E C Veerman; A V Nieuw Amerongen
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

6.  mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides.

Authors:  Igor E Brodsky; Robert K Ernst; Samuel I Miller; Stanley Falkow
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

7.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli.

Authors:  S Stumpe; R Schmid; D L Stephens; G Georgiou; E P Bakker
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

9.  Subcellular Min oscillations as a single-cell reporter of the action of polycations, protamine, and gentamicin on Escherichia coli.

Authors:  Benjamin P B Downing; Andrew D Rutenberg; Ahmed Touhami; Manfred Jericho
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

10.  Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).

Authors:  Heng-Li Chen; Pei-Yi Su; Ya-Shu Chang; Szu-Yao Wu; You-Di Liao; Hui-Ming Yu; Tsai-Ling Lauderdale; Kaichih Chang; Chiaho Shih
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.